Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.

Janne Cadamuro; Benjamin Dieplinger; Thomas Felder; Igor Kedenko; Thomas Mueller; Meinhard Haltmayer; Wolfgang Patsch; Hannes Oberkofler

doi:10.1007/s00228-009-0768-7

Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.

Janne Cadamuro (First author)
, Benjamin Dieplinger
, Thomas Felder (Co-author)
, Igor Kedenko
, Thomas Mueller
, Meinhard Haltmayer
, Wolfgang Patsch (Co-author)
, Hannes Oberkofler

Department of Labratory Medicine

Research output: Contribution to journal › Original Article › peer-review

41 Citations (Web of Science)

Original language	English
Pages (from-to)	253-260
Journal	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume	66
Issue number	3
DOIs	https://doi.org/10.1007/s00228-009-0768-7
Publication status	Published - 2010

Keywords

K EPOXIDE REDUCTASE
GAMMA-CARBOXYLATION SYSTEM
CYTOCHROME P4502C9
BLEEDING COMPLICATIONS
ANTICOAGULANT RESPONSE
GLUTAMYL CARBOXYLASE
ORAL ANTICOAGULANTS
VKORC1 HAPLOTYPES
WARFARIN
CYP2C9

Access to Document

10.1007/s00228-009-0768-7

Cite this

Cadamuro, J., Dieplinger, B., Felder, T., Kedenko, I., Mueller, T., Haltmayer, M., Patsch, W., & Oberkofler, H. (2010). Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , 66(3), 253-260. https://doi.org/10.1007/s00228-009-0768-7

Cadamuro, Janne ; Dieplinger, Benjamin ; Felder, Thomas et al. / Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. In: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2010 ; Vol. 66, No. 3. pp. 253-260.

@article{82029508ae6a4771ad71da8835530209,

title = "Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.",

keywords = "K EPOXIDE REDUCTASE, GAMMA-CARBOXYLATION SYSTEM, CYTOCHROME P4502C9, BLEEDING COMPLICATIONS, ANTICOAGULANT RESPONSE, GLUTAMYL CARBOXYLASE, ORAL ANTICOAGULANTS, VKORC1 HAPLOTYPES, WARFARIN, CYP2C9",

author = "Janne Cadamuro and Benjamin Dieplinger and Thomas Felder and Igor Kedenko and Thomas Mueller and Meinhard Haltmayer and Wolfgang Patsch and Hannes Oberkofler",

year = "2010",

doi = "10.1007/s00228-009-0768-7",

language = "English",

volume = "66",

pages = "253--260",

journal = "EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY ",

issn = "0031-6970",

number = "3",

}

Cadamuro, J, Dieplinger, B, Felder, T, Kedenko, I, Mueller, T, Haltmayer, M, Patsch, W & Oberkofler, H 2010, 'Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.', EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol. 66, no. 3, pp. 253-260. https://doi.org/10.1007/s00228-009-0768-7

Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. / Cadamuro, Janne (First author); Dieplinger, Benjamin; Felder, Thomas (Co-author) et al.
In: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , Vol. 66, No. 3, 2010, p. 253-260.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.

AU - Cadamuro, Janne

AU - Dieplinger, Benjamin

AU - Felder, Thomas

AU - Kedenko, Igor

AU - Mueller, Thomas

AU - Haltmayer, Meinhard

AU - Patsch, Wolfgang

AU - Oberkofler, Hannes

PY - 2010

Y1 - 2010

KW - K EPOXIDE REDUCTASE

KW - GAMMA-CARBOXYLATION SYSTEM

KW - CYTOCHROME P4502C9

KW - BLEEDING COMPLICATIONS

KW - ANTICOAGULANT RESPONSE

KW - GLUTAMYL CARBOXYLASE

KW - ORAL ANTICOAGULANTS

KW - VKORC1 HAPLOTYPES

KW - WARFARIN

KW - CYP2C9

U2 - 10.1007/s00228-009-0768-7

DO - 10.1007/s00228-009-0768-7

M3 - Original Article

C2 - 20020283

SN - 0031-6970

VL - 66

SP - 253

EP - 260

JO - EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

JF - EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

IS - 3

ER -

Cadamuro J, Dieplinger B, Felder T, Kedenko I, Mueller T, Haltmayer M et al. Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY . 2010;66(3):253-260. doi: 10.1007/s00228-009-0768-7